| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
60,313 |
43,782 |
$2.22M |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
11,041 |
10,251 |
$803K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
16,878 |
15,399 |
$662K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
28,298 |
13,137 |
$380K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
4,617 |
4,466 |
$345K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
4,265 |
4,161 |
$337K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
22,300 |
20,285 |
$298K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
2,857 |
2,809 |
$249K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
3,174 |
3,071 |
$233K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
18,541 |
7,505 |
$199K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
1,270 |
1,233 |
$93K |
| 99429 |
|
2,165 |
2,128 |
$67K |
| 87634 |
|
1,114 |
1,014 |
$54K |
| 99382 |
|
582 |
580 |
$52K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
3,706 |
2,850 |
$45K |
| 99381 |
|
559 |
547 |
$44K |
| 87807 |
|
4,006 |
3,621 |
$42K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
6,388 |
5,696 |
$40K |
| 99051 |
|
6,606 |
5,859 |
$31K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
332 |
326 |
$27K |
| 92558 |
|
4,211 |
4,130 |
$24K |
| 90461 |
|
5,213 |
4,442 |
$22K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
2,706 |
2,646 |
$22K |
| 99383 |
|
148 |
145 |
$12K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
185 |
179 |
$9K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
124 |
124 |
$8K |
| 83655 |
|
613 |
605 |
$6K |
| 97169 |
|
298 |
291 |
$5K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
2,367 |
1,628 |
$4K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
92 |
89 |
$3K |
| 81002 |
|
1,136 |
1,078 |
$3K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
92 |
85 |
$2K |
| 84030 |
|
507 |
487 |
$2K |
| 86318 |
|
139 |
131 |
$2K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
100 |
100 |
$1K |
| 80053 |
Comprehensive metabolic panel |
160 |
151 |
$1K |
| 90620 |
|
417 |
413 |
$648.47 |
| 86580 |
|
89 |
89 |
$638.74 |
| 92587 |
|
44 |
44 |
$561.84 |
| 90651 |
|
581 |
579 |
$561.58 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
45 |
44 |
$508.50 |
| 96160 |
|
450 |
445 |
$456.50 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
362 |
351 |
$403.50 |
| 85018 |
|
347 |
344 |
$322.38 |
| 97802 |
|
2,593 |
2,534 |
$200.06 |
| 90619 |
|
448 |
443 |
$159.61 |
| 90686 |
|
1,374 |
1,359 |
$127.31 |
| 90715 |
|
337 |
330 |
$102.88 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
776 |
725 |
$43.56 |
| 99174 |
|
4,511 |
4,429 |
$17.50 |
| 96161 |
|
65 |
64 |
$9.00 |
| G0447 |
Face-to-face behavioral counseling for obesity, 15 minutes |
9,004 |
8,778 |
$5.25 |
| 90677 |
|
705 |
701 |
$1.53 |
| 90688 |
|
68 |
68 |
$0.04 |
| 90734 |
|
402 |
397 |
$0.01 |
| 90647 |
|
2,588 |
2,565 |
$0.00 |
| 90723 |
|
2,007 |
1,988 |
$0.00 |
| 4140F |
|
16 |
15 |
$0.00 |
| 90696 |
|
350 |
342 |
$0.00 |
| 90680 |
|
1,960 |
1,939 |
$0.00 |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
6,396 |
6,249 |
$0.00 |
| 3120F |
|
21,983 |
20,020 |
$0.00 |
| 90716 |
|
408 |
405 |
$0.00 |
| G8418 |
Bmi is documented below normal parameters and a follow-up plan is documented |
125 |
124 |
$0.00 |
| G0010 |
Administration of hepatitis b vaccine |
686 |
675 |
$0.00 |
| 36416 |
|
59 |
54 |
$0.00 |
| 3330F |
|
49 |
49 |
$0.00 |
| G0008 |
Administration of influenza virus vaccine |
70 |
70 |
$0.00 |
| 90710 |
|
519 |
507 |
$0.00 |
| 90707 |
|
371 |
368 |
$0.00 |
| 90633 |
|
1,368 |
1,358 |
$0.00 |
| 90670 |
|
2,014 |
1,989 |
$0.00 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
2,852 |
2,778 |
$0.00 |
| 99173 |
|
52 |
52 |
$0.00 |
| 90700 |
|
465 |
464 |
$0.00 |
| 90649 |
|
208 |
199 |
$0.00 |